Results 171 to 180 of about 2,436,024 (405)

Symptom Clusters and Their Impact on Spiritual Well-Being Among Women with Breast Cancer

International Journal of Women's Health
Randa M Albusoul,1 Amer A Hasanien,1 Nadin M Abdel Razeq,2 Dua’ Y Al-Maharma2 1Clinical Nursing Department, School of Nursing, The University of Jordan, Amman, Jordan; 2Department of Maternal and Child Health Nursing, School of Nursing, The University of
Albusoul RM, Hasanien AA, Abdel Razeq NM, Al-Maharma DY   +3 more
doaj  

Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children’s Oncology Group

, 2016
Robert B. Gerbing, Todd A. Alonzo, Lillian Sung, Alan S. Gamis, Soheil Meshinchi, Sharon E. Plon, Alison A. Bertuch, M. Monica Gramatges   +7 more
openalex   +2 more sources

Biweekly 72-Hour 9-Aminocamptothecin Infusion As Second-Line Therapy for Ovarian Carcinoma: Phase II Study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group [PDF]

, 2003
Howard S. Höchster, Elizabeth R. Plimack, Carolyn D. Runowicz, James L. Speyer, Robert C. Wallach, Joan Sorich, John Mandeli, Scott Wadler, James R. Wright, Franco M. Muggia   +9 more
openalex   +1 more source

Oncology meets immunology: the cancer-immunity cycle.

Immunity, 2013
Daniel S. Chen, I. Mellman
semanticscholar   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Doing Palliative Care in the Oncology Office

, 2013
Menglin Cheng, Lauren M. King, Erin R. Alesi, Thomas J. Smith   +3 more
openalex   +2 more sources

Medical Oncology: Medical Aspects of Malignant Disease [PDF]

, 1975
D. Crowther
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond

Breast Cancer: Targets and Therapy
Alex Agelidis,1,2 Anna Ter-Zakarian,1 Mohammed Jaloudi1 1Scripps Cancer Center, Scripps Health, La Jolla, California, USA; 2Scripps Translational Research Institute, Scripps Research, La Jolla, California, USACorrespondence: Mohammed Jaloudi, Email ...
Agelidis A, Ter-Zakarian A, Jaloudi M
doaj  

Geriatric Oncology [PDF]

Age and Ageing, 2009
openaire   +2 more sources